DK

Rasmus Lundquist

This inventor holds 0 USPTO granted patents, plus 10 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rasmus Lundquist. Retrieved from https://idiyas.com/inventor/rasmus-lundquist-ql5u2c91

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Rasmus Lundquist: A Key Contributor at Reapplix Aps

Introduction

Rasmus Lundquist is a prominent figure in the field of medical innovations, currently working at Reapplix ApS in Denmark. Although he has not yet secured any patents, his collaborative spirit and contributions to the industry are noteworthy, especially as he works alongside skilled professionals like Niels Erik Holm.

Latest Patents

As of now, Rasmus Lundquist does not hold any patents. However, his role in his current company may lead to future developments and innovations in the medical sector.

Career Highlights

Rasmus has a commendable career at Reapplix ApS, where he focuses on advancements in medical technology. His work contributes to the company's mission of providing innovative treatment solutions, reflecting his commitment to enhancing patient care and outcomes.

Collaborations

Rasmus Lundquist collaborates closely with Niels Erik Holm, leveraging their combined skills and knowledge to foster innovation at Reapplix ApS. This partnership highlights the importance of teamwork in the development of new technologies and solutions.

Conclusion

Though Rasmus Lundquist has yet to file patents, his role and collaborations at Reapplix ApS showcase his potential impact on the medical field. As he continues to work alongside talented colleagues, he may soon contribute to significant innovations that could transform healthcare practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…